Current and future recanalization strategies for acute ischemic stroke

Area of Science:

• Neurology
• Cardiovascular Medicine
• Biomedical Engineering

Background:

• Reperfusion is critical for treating acute ischemic stroke.
• Systemic tissue plasminogen activator (tPA) is the primary approved thrombolytic therapy.
• Large thrombus burden often leads to incomplete recanalization with tPA alone.

Purpose of the Study:

• To review current and emerging strategies for improving recanalization in acute ischemic stroke.
• To evaluate the efficacy of various thrombolytic and revascularization techniques.
• To identify challenges and future directions in stroke treatment.

Main Methods:

• Review of existing clinical practices and ongoing clinical trials.
• Analysis of strategies including accelerated tPA infusion, sonothrombolysis, and intra-arterial revascularization.
• Discussion of mechanical thrombectomy, aspiration, and novel experimental approaches.

Main Results:

• No single strategy has emerged as a definitive 'silver bullet' for acute ischemic stroke.
• Faster treatment initiation and early, even partial, flow improvement correlate with better outcomes.
• Arterial re-occlusion is a significant challenge with current methods, lacking established preventative strategies.

Conclusions:

• Multimodal approaches and rapid intervention are key to improving stroke outcomes.
• Further research is needed to address arterial re-occlusion and optimize recanalization.
• Advancements in reperfusion therapies offer hope for more effective acute ischemic stroke management.